NEW YORK, May 15, 2015 /PRNewswire/ -- The following
statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise
acquired securities of Cellular Biomedicine Group Inc.
(NASDAQ: CBMG) between June 18,
2014 and April 7,
2015.
You are hereby notified that a securities class action
lawsuit has been commenced in the United States District Court for
the Northern District of California. If you purchased or otherwise
acquired Cellular Biomedicine Group Inc. ("Cellular Biomedicine")
securities between June 18, 2014 and
April 7, 2015, your rights
may be affected by this action. To get more information go
to:
http://zlkdocs.com/CBMG-Info-Request-Form-2850
or contact Joseph E. Levi, Esq.
either via email at jlevi@zlk.com or by telephone at (212)
363-7500, toll-free: (877) 363-5972. There is no cost or
obligation to you.
The complaint alleges that, among other allegations, the Company
used paid stock promoters to achieve its $500 million valuation, but failed to disclose
the use of promoters in its regulatory filings.
On April 7, 2015, an article
featured on Seeking Alpha alleged that the Company was engaged in a
fraudulent scheme to mislead investors.
If you suffered a loss in Cellular Biomedicine you have until
June 22, 2015 to request that the
Court appoint you as lead plaintiff. Your ability to share in any
recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior
results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY
10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-llp-notifies-shareholders-of-cellular-biomedicine-group-inc-of-pendency-of-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-june-22-2015--cbmg-300084125.html
SOURCE Levi & Korsinsky, LLP